Exchange: HKSE Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
0.00% HKD0.0980
America/New_York / 2 mai 2024 @ 03:10
FUNDAMENTALS | |
---|---|
MarketCap: | 49.05 mill |
EPS: | -0.0200 |
P/E: | -4.90 |
Earnings Date: | Mar 28, 2024 |
SharesOutstanding: | 500.47 mill |
Avg Daily Volume: | 1.707 mill |
RATING 2024-05-02 |
---|
C+ |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Sell | |
Return On Equity: | Strong Sell | |
Return On Asset: | Sell | |
DE: | Neutral | |
P/E: | Sell | |
Price To Book: | Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | n/a | n/a | n/a | |||
Debt | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -4.90 | sector: PE 34.76 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.37x |
Company: PE -4.90 | industry: PE 13.09 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
HKD 0.0890 - 0.107 ( +/- 9.18%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 |
Volume Signals | |
---|---|
Price | HKD0.0980 (0.00% ) |
Volume | 0.0480 mill |
Avg. Vol. | 1.707 mill |
% of Avg. Vol | 2.81 % |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Huakang Biomedical Holdings Company Limited, an investment holding company, engages in the research, development, manufacture, marketing, and sale of in-vitro diagnostic (IVD) reagents in the People's Republic of China. It offers male and female fertility IVD, parasite antibody detection, and Epstein-Barr virus antibody detection reagents; auxiliary reproductive supplies and equipment; and healthcare products and supplements under the Nutronic brand to customers, as well as through online and offline platforms and channels. The company sells its products directly to hospitals and medical institutions, as well as to distributors. Huakang Biomedical Holdings Company Limited was founded in 1992 and is headquartered in Wan Chai, Hong Kong.